SCHEMBL6282205

SCHEMBL6282205

CC(=CC(=O)O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14906814 1.00
SCHEMBL8370948 1.00
SCHEMBL11442823 0.79 KDM4E (0.70)
SCHEMBL11442824 0.79 KDM4E (0.70)
SCHEMBL11442822 0.79 KDM4E (0.70)
SCHEMBL30499040 0.79 KDM4E (0.70)
SCHEMBL1703735 0.79
SCHEMBL1703734 0.79
SCHEMBL648808 0.78
SCHEMBL8372870 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240002313-A1 [11C]-LABELED ACYCLIC RETINOID, CENTRAL NERVOUS SYSTEM ACTIVATOR, AND PRODUCTION METHODS FOR SAME NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY (JP) 2024-01-04 US disclosed
EP-4249058-A1 [11C]-LABELLED ACYCLIC RETINOID, CENTRAL NERVOUS SYSTEM ACTIVATOR, AND PRODUCTION METHODS FOR SAME National Center for Geriatrics and Gerontology (JP) 2023-09-27 EP disclosed
EP-3981766-A1 INDAZOLE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER Eisai R&D Management Co., Ltd. (JP) 2022-04-13 EP disclosed
CN-113024466-A Tetra-substituted olefin compound and use thereof 卫材 R&D 管理有限公司 2021-06-25 CN disclosed
CN-107847498-B Tetra-substituted olefin compound and use thereof 卫材R&D管理有限公司 2021-04-13 CN disclosed
US-10919835-B2 Compounds and synthetic methods for the preparation of retinoid X receptor-specific retinoids Io Therapeutics, Inc. (US) 2021-02-16 US disclosed
US-10851065-B2 Tetrasubstituted alkene compounds and their use EISAI R&D MANAGEMENT CO., LTD. (JP) 2020-12-01 US disclosed
US-20200190008-A1 COMPOUNDS AND SYNTHETIC METHODS FOR THE PREPARATION OF RETINOID X RECEPTOR-SPECIFIC RETINOIDS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2020-06-18 US disclosed
CN-108026088-A Oxadiazole derivatives as HDAC inhibitors 武田药品工业株式会社 2018-05-11 CN disclosed
US-20180127378-A1 TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE EISAI R&D MANAGEMENT CO., LTD. (JP) 2018-05-10 US disclosed
US-4537720-A N-substituted-2-(R)-(sulfinic acid)-3-(S)-(acylamino)-4-oxo-azetidines and process ELI LILLY AND COMPANY (US) 1985-08-27 US disclosed
EP-0109816-A1 N-substituted-2-(R)-(sulfinic acid)-3-(S)-(acylamido)-4-oxo-azetidines and process ELI LILLY AND COMPANY (US) 1984-05-30 EP disclosed
US-4444621-A Process and apparatus for the deresination and brightness improvement of cellulose pulp MO OCH DOMSJO AKTIEBOLAG (SE) 1984-04-24 US disclosed
US-4436596-A N-Substituted-2-(R)-(sulfinic acid)-3-(S)-(acylamido)-4-oxo-azetidines and process ELI LILLY AND COMPANY (US) 1984-03-13 US disclosed
US-4372811-A INHIBITION OF DEGRADATION OF CARBOHYDRATES MO OCH DOMSJO AKTIEBOLAG (SE) 1983-02-08 US disclosed
US-4244778-A BLEACHING IN A SHORT PROCESSING TIME MODO-CHEMETICS AB (SE) 1981-01-13 US disclosed
US-4222819-A COMPLEXING AGENT TO INHIBIT ATTACK ON CELLULOSE, DELIGNIFICATION MO OCH DOMSJO AKTIEBOLAG (SE) 1980-09-16 US disclosed
US-4087318-A Oxygen-alkali delignification of lignocellulosic material in the presence of a manganese compound MO OCH DOMSJO AKTIEBOLAG (SW) 1978-05-02 US disclosed
US-4050981-A Process for the delignification of lignocellulosic material by maintaining a concentration of carbon monoxide in the presence of oxygen and alkali MO OCH DOMSJO AKTIEBOLAG (SW) 1977-09-27 US disclosed
US-4016029-A CONTACTING WITH OXYGEN AND SODIUM BICARBONATE, REMOVING CARBON DIOXIDE MO OCH DOMSJO AKTIEBOLAG (SW) 1977-04-05 US disclosed